Treffer: Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition.
Title:
Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition.
Authors:
Bharadwaj S; Center for SeNSE, Indian Institute of Technology Delhi (IIT), New Delhi, India., Deepika K; Department of Computer Engineering, Pune Institute of Computer Technology, Pune, India., Kumar A; Amity Institute of Pharmacy (AIP), Amity University Haryana, Manesar, India., Jaiswal S; Institute of Pharmaceutical Research, GLA University, Mathura, India., Miglani S; Department of Education, Central University of Punjab, Bathinda, India., Singh D; IES Institute of Pharmacy, IES University, Bhopal, Madhya Pradesh, India., Fartyal P; Department of Mathematics, Govt PG College Bajpur (US Nagar), Bazpur, Uttarakhand, India., Kumar R; Department of Microbiology, Graphic Era (Deemed to be University), Dehradun, India.; Department of Microbiology, Central University of Punjab, VPO-Ghudda, Punjab, India., Singh S; Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India., Singh MP; Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India., Gaidhane AM; Jawaharlal Nehru Medical College, and Global Health Academy, School of Epidemiology and Public Health, Datta Meghe Institute of Higher Education, Wardha, India., Kumar B; Department of Pharmaceutical Science, Hemvati Nandan Bahuguna Garhwal (A Central) University, Srinagar, Uttarakhand, India., Jha V; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Bradford, UK.
Source:
Chemical biology & drug design [Chem Biol Drug Des] 2024 Oct; Vol. 104 (4), pp. e14639.
Publication Type:
Journal Article; Review
Language:
English
Journal Info:
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print Cited Medium: Internet ISSN: 1747-0285 (Electronic) Linking ISSN: 17470277 NLM ISO Abbreviation: Chem Biol Drug Des Subsets: MEDLINE
Imprint Name(s):
Original Publication: Oxford : Wiley-Blackwell, 2006-
MeSH Terms:
References:
Abe, H., S. Kumazawa, T. Taji, and S. I. Sasaki. 1976. “Applications of Computerized Pattern Recognition: A Survey of Correlations Between Pharmacological Activities and Mass Spectra.” Biomedical Mass Spectrometry 3, no. 4: 151–154.
Abramson, J., J. Adler, J. Dunger, et al. 2024. “Accurate Structure Prediction of Biomolecular Interactions With AlphaFold 3.” Nature 630, no. 8016: 493–500. https://doi.org/10.1038/s41586‐024‐07487‐w.
Achenbach, J., P. Tiikkainen, L. Franke, and E. Proschak. 2011. “Computational Tools for Polypharmacology and Repurposing.” Future Medicinal Chemistry 3, no. 8: 961–968.
Aksu, B., A. Paradkar, M. de Matas, Ö. Özer, T. Güneri, and P. York. 2013. “A Quality by Design Approach Using Artificial Intelligence Techniques to Control the Critical Quality Attributes of Ramipril Tablets Manufactured by Wet Granulation.” Pharmaceutical Development and Technology 18, no. 1: 236–245.
Alaloul, W. S., and A. H. Qureshi. 2020. “Data Processing Using Artificial Neural Networks.” Dynamic Data Assimilation‐Beating the Uncertainties. https://dx.doi.org/10.5772/intechopen.91935.
Al‐Faris, M., J. Chiverton, D. Ndzi, and A. I. Ahmed. 2020. “A Review on Computer Vision‐Based Methods for Human Action Recognition.” Journal of Imaging 6, no. 6: 46. https://doi.org/10.3390/jimaging6060046.
Álvarez‐Machancoses, Ó., and J. L. Fernández‐Martínez. 2019. “Using Artificial Intelligence Methods to Speed Up Drug Discovery.” Expert Opinion on Drug Discovery 14, no. 8: 769–777.
Ammari, M. G., C. R. Gresham, F. M. McCarthy, and B. Nanduri. 2016. “HPIDB 2.0: A Curated Database for Host–Pathogen Interactions.” Database 2016: baw103.
Anderson, J. A. 1995. An Introduction to Neural Networks. Cambridge, MA: MIT Press.
Baek, M., F. DiMaio, I. Anishchenko, et al. 2021. “Accurate Prediction of Protein Structures and Interactions Using a Three‐Track Neural Network.” Science 373, no. 6557: 871–876. https://doi.org/10.1126/science.abj8754.
Bai, Q., S. Tan, T. Xu, H. Liu, J. Huang, and X. Yao. 2021. “MolAICal: A Soft Tool for 3D Drug Design of Protein Targets by Artificial Intelligence and Classical Algorithm.” Briefings in Bioinformatics 22, no. 3: bbaa161.
Bajorath, J. 2023. “Generative Kinase Inhibitor Modeling Viewed From a Medicinal Chemistry Perspective.” Future Medicinal Chemistry 15, no. 4: 313–315.
Bajorath, J., S. Kearnes, W. P. Walters, N. A. Meanwell, G. I. Georg, and S. Wang. 2020. “Artificial Intelligence in Drug Discovery: Into the Great Wide Open.” Journal of Medicinal Chemistry 63, no. 16: 8651–8652. https://doi.org/10.1021/acs.jmedchem.0c01077.
Bakkar, N., T. Kovalik, I. Lorenzini, et al. 2018. “Artificial Intelligence in Neurodegenerative Disease Research: Use of IBM Watson to Identify Additional RNA‐Binding Proteins Altered in Amyotrophic Lateral Sclerosis.” Acta Neuropathologica 135, no. 2: 227–247.
Bannigan, P., M. Aldeghi, Z. Bao, F. Häse, A. Aspuru‐Guzik, and C. Allen. 2021. “Machine Learning Directed Drug Formulation Development.” Advanced Drug Delivery Reviews 175: 113806.
Basile, A. O., A. Yahi, and N. P. Tatonetti. 2019. “Artificial Intelligence for Drug Toxicity and Safety.” Trends in Pharmacological Sciences 40, no. 9: 624–635.
Bateman, J., and M. Zock. 2003. “Natural Language Generation.” In The Oxford Handbook of Computational Linguistics, edited by R. Mitkov. Oxford, UK: Oxford Academic.
Bates, M. 1995. “Models of Natural Language Understanding.” Proceedings of the National Academy of Sciences of the United States of America 92, no. 22: 9977–9982.
Belkin, M., P. Niyogi, and V. Sindhwani. 2006. “Manifold Regularization: A Geometric Framework for Learning From Labeled and Unlabeled Examples.” Journal of Machine Learning Research 7, no. 11: 2399–2434.
Bertinetto, L., J. Valmadre, J. F. Henriques, A. Vedaldi, and P. H. Torr. 2016. “Fully‐Convolutional Siamese Networks for Object Tracking.” Paper Presented at the Computer Vision‐ECCV 2016 Workshops: Amsterdam, The Netherlands, October 8–10 and 15–16, 2016, Proceedings, Part II 14.
Besnard, J., G. F. Ruda, V. Setola, et al. 2012. “Automated Design of Ligands to Polypharmacological Profiles.” Nature 492, no. 7428: 215–220.
Bess, A., F. Berglind, S. Mukhopadhyay, et al. 2022. “Artificial Intelligence for the Discovery of Novel Antimicrobial Agents for Emerging Infectious Diseases.” Drug Discovery Today 27, no. 4: 1099–1107.
Bhirde, A. A., M.‐J. Chiang, R. Venna, S. Beaucage, and K. Brorson. 2018. “High‐Throughput In‐Use and Stress Size Stability Screening of Protein Therapeutics Using Algorithm‐Driven Dynamic Light Scattering.” Journal of Pharmaceutical Sciences 107, no. 8: 2055–2062.
Bishop, C. M. 1994. “Neural Networks and Their Applications.” Review of Scientific Instruments 65, no. 6: 1803–1832.
Bishop, C. M., and N. M. Nasrabadi. 2006. Pattern Recognition and Machine Learning. Vol. 4. New York: Springer.
Blasiak, A., J. Khong, and T. Kee. 2020. “CURATE. AI: Optimizing Personalized Medicine With Artificial Intelligence.” SLAS Technology 25, no. 2: 95–105.
Cañada, A., S. Capella‐Gutierrez, O. Rabal, J. Oyarzabal, A. Valencia, and M. Krallinger. 2017. “LimTox: A Web Tool for Applied Text Mining of Adverse Event and Toxicity Associations of Compounds, Drugs and Genes.” Nucleic Acids Research 45, no. W1: W484–W489.
Carrella, D., F. Napolitano, R. Rispoli, et al. 2014. “Mantra 2.0: An Online Collaborative Resource for Drug Mode of Action and Repurposing by Network Analysis.” Bioinformatics 30, no. 12: 1787–1788.
Chai, J., H. Zeng, A. Li, and E. W. T. Ngai. 2021. “Deep Learning in Computer Vision: A Critical Review of Emerging Techniques and Application Scenarios.” Machine Learning with Applications 6: 100134. https://doi.org/10.1016/j.mlwa.2021.100134.
Chakraborty, S., S. K. Islam, and D. Samanta. 2022. “A Brief Concept on Machine Learning.” In Data Classification and Incremental Clustering in Data Mining and Machine Learning, 23–32. Germany: Springer.
Chan, H. S., H. Shan, T. Dahoun, H. Vogel, and S. Yuan. 2019. “Advancing Drug Discovery via Artificial Intelligence.” Trends in Pharmacological Sciences 40, no. 8: 592–604.
Chen, H., and Z. Zhang. 2013. “A Semi‐Supervised Method for Drug–Target Interaction Prediction With Consistency in Networks.” PLoS One 8, no. 5: e62975.
Chen, J., Z. Wang, C.‐M. Li, et al. 2010. “Discovery of Novel 2‐Aryl‐4‐Benzoyl‐Imidazoles Targeting the Colchicines Binding Site in Tubulin as Potential Anticancer Agents.” Journal of Medicinal Chemistry 53, no. 20: 7414–7427.
Chen, J. J. F., and D. P. Visco Jr. 2017. “Developing an In Silico Pipeline for Faster Drug Candidate Discovery: Virtual High Throughput Screening With the Signature Molecular Descriptor Using Support Vector Machine Models.” Chemical Engineering Science 159: 31–42.
Chen, L., H. Deng, H. Cui, et al. 2018. “Inflammatory Responses and Inflammation‐Associated Diseases in Organs.” Oncotarget 9, no. 6: 7204–7218.
Chen, W., D. Desai, D. Good, et al. 2016. “Mathematical Model‐Based Accelerated Development of Extended‐Release Metformin Hydrochloride Tablet Formulation.” AAPS PharmSciTech 17, no. 4: 1007–1013.
Chen, X., D. Zou, H. Xie, G. Cheng, and C. Liu. 2022. “Two Decades of Artificial Intelligence in Education.” Educational Technology & Society 25, no. 1: 28–47.
Cheng, F., W. Li, Y. Zhou, et al. 2012. “admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties.” Journal of Chemical Information and Modeling 52, no. 11: 3099–3105.
Ching, T., D. S. Himmelstein, B. K. Beaulieu‐Jones, et al. 2018. “Opportunities and Obstacles for Deep Learning in Biology and Medicine.” Journal of the Royal Society Interface 15, no. 141: 20170387.
Chiu, C.‐Y., Y.‐F. Chen, I.‐T. Kuo, and H. C. Ku. 2009. “An Intelligent Market Segmentation System Using k‐Means and Particle Swarm Optimization.” Expert Systems with Applications 36, no. 3: 4558–4565.
Chowdhary, K. R. 2020. “Natural Language Processing.” In Fundamentals of Artificial Intelligence, 603–649. New Delhi: Springer. https://doi.org/10.1007/978‐81‐322‐3972‐7_19.
Cid Vidal, X., L. Dieste Maroñas, and Á. Dosil Suárez. 2022. “Modern Machine Learning: Applications and Methods.” In Machine Learning and Artificial Intelligence With Industrial Applications, 19–61. Cham, Switzerland: Springer.
Coleman, C. M., J. M. Sisk, R. M. Mingo, E. A. Nelson, J. M. White, and M. B. Frieman. 2016. “Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.” Journal of Virology 90, no. 19: 8924–8933.
Coley, C. W., R. Barzilay, W. H. Green, T. S. Jaakkola, and K. F. Jensen. 2017. “Convolutional Embedding of Attributed Molecular Graphs for Physical Property Prediction.” Journal of Chemical Information and Modeling 57, no. 8: 1757–1772.
Coley, C. W., R. Barzilay, T. S. Jaakkola, W. H. Green, and K. F. Jensen. 2017. “Prediction of Organic Reaction Outcomes Using Machine Learning.” ACS Central Science 3, no. 5: 434–443.
Coley, C. W., W. H. Green, and K. F. Jensen. 2019. “RDChiral: An RDKit Wrapper for Handling Stereochemistry in Retrosynthetic Template Extraction and Application.” Journal of Chemical Information and Modeling 59, no. 6: 2529–2537.
Collatuzzo, G., and P. Boffetta. 2022. “Application of P4 (Predictive, Preventive, Personalized, Participatory) Approach to Occupational Medicine.” La Medicina del Lavoro 113, no. 1: e2022009.
Collins, K. D., and F. Glorius. 2013. “A Robustness Screen for the Rapid Assessment of Chemical Reactions.” Nature Chemistry 5, no. 7: 597–601.
Colombo, S. 2020. “Applications of Artificial Intelligence in Drug Delivery and Pharmaceutical Development.” In Artificial Intelligence in Healthcare, 85–116. Massachusetts: Elsevier.
Dana, D., S. V. Gadhiya, L. G. St. Surin, et al. 2018. “Deep Learning in Drug Discovery and Medicine; Scratching the Surface.” Molecules 23, no. 9: 2384.
Das, B. R., D. Singh, P. C. Bhoi, and D. Mishra. 2021. “Role of Intelligent Techniques in Natural Language Processing: An Empirical Study.” In Intelligent and Cloud Computing, 481–490. Singapore: Springer.
de Almeida, A. F., R. Moreira, and T. Rodrigues. 2019. “Synthetic Organic Chemistry Driven by Artificial Intelligence.” Nature Reviews Chemistry 3, no. 10: 589–604.
Deiana, A. M., N. Tran, J. Agar, et al. 2022. “Applications and Techniques for Fast Machine Learning in Science.” Frontiers in Big Data 5: 787421.
Delso, G., D. Cirillo, J. D. Kaggie, A. Valencia, U. Metser, and P. Veit‐Haibach. 2021. “How to Design AI‐Driven Clinical Trials in Nuclear Medicine.” Paper Presented at the Seminars in Nuclear Medicine.
Dhall, D., R. Kaur, and M. Juneja. 2020. “Machine Learning: A Review of the Algorithms and Its Applications.” Proceedings of ICRIC 2019: 47–63.
Dong, S., P. Wang, and K. Abbas. 2021. “A Survey on Deep Learning and Its Applications.” Computer Science Review 40: 100379.
Drăgoi, E. N., S. Curteanu, and D. Fissore. 2013. “On the Use of Artificial Neural Networks to Monitor a Pharmaceutical Freeze‐Drying Process.” Drying Technology 31, no. 1: 72–81.
Drew, K., C. Lee, R. L. Huizar, et al. 2017. “Integration of Over 9,000 Mass Spectrometry Experiments Builds a Global Map of Human Protein Complexes.” Molecular Systems Biology 13, no. 6: 932.
Dudley, J. T., T. Deshpande, and A. J. Butte. 2011. “Exploiting Drug–Disease Relationships for Computational Drug Repositioning.” Briefings in Bioinformatics 12, no. 4: 303–311.
Fan, J., M. Campbell, and B. Kingsbury. 2011. “Artificial Intelligence Research at IBM.” IBM Journal of Research and Development 55, no. 5: 16:1–16:4.
Fang, X., S. Bagui, and S. Bagui. 2017. “Improving Virtual Screening Predictive Accuracy of Human Kallikrein 5 Inhibitors Using Machine Learning Models.” Computational Biology and Chemistry 69: 110–119.
Ferrero, E., I. Dunham, and P. Sanseau. 2017. “In Silico Prediction of Novel Therapeutic Targets Using Gene–Disease Association Data.” Journal of Translational Medicine 15, no. 1: 1–16.
Fialkowski, M., K. J. Bishop, V. A. Chubukov, C. J. Campbell, and B. A. Grzybowski. 2005. “Architecture and Evolution of Organic Chemistry.” Angewandte Chemie International Edition 44, no. 44: 7263–7269.
Fogel, D. B. 2018. “Factors Associated With Clinical Trials That Fail and Opportunities for Improving the Likelihood of Success: A Review.” Contemporary Clinical Trials Communications 11: 156–164.
Frey, B. J., and D. Dueck. 2007. “Clustering by Passing Messages Between Data Points.” Science 315, no. 5814: 972–976.
Fu, J., and H. Yan. 2012. “Controlled Drug Release by a Nanorobot.” Nature Biotechnology 30, no. 5: 407–408.
Gallant, S. I. 1990. “Perceptron‐Based Learning Algorithms.” IEEE Transactions on Neural Networks 1, no. 2: 179–191.
Gams, M., M. Horvat, M. Ožek, M. Luštrek, and A. Gradišek. 2014. “Integrating Artificial and Human Intelligence Into Tablet Production Process.” AAPS PharmSciTech 15, no. 6: 1447–1453.
Gayvert, K. M., N. S. Madhukar, and O. Elemento. 2016. “A Data‐Driven Approach to Predicting Successes and Failures of Clinical Trials.” Cell Chemical Biology 23, no. 10: 1294–1301.
Gentleman, R., and V. J. Carey. 2008. “Unsupervised Machine Learning.” In Bioconductor Case Studies, 137–157. New York, NY: Springer.
Gnanasankaran, N., G. Rakesh, and T. Manikumar. 2022. “Multidisciplinary Applications of Machine Learning.” In Machine Learning, Blockchain, and Cyber Security in Smart Environments, 41–57. Florida: Chapman and Hall/CRC.
GNS Healthcare Announces Collaboration to Power Cancer Drug Development With REFS™ Causal Machine Learning and Simulation AI Platform. 2023. https://www.gnshealthcare.com/gns‐healthcare‐announces‐collaboration‐to‐power‐cancer‐drug‐development/.
Goh, W. Y., C. P. Lim, K. K. Peh, and K. Subari. 2002. “Application of a Recurrent Neural Network to Prediction of Drug Dissolution Profiles.” Neural Computing & Applications 10, no. 4: 311–317.
Gottlieb, A., G. Y. Stein, E. Ruppin, and R. Sharan. 2011. “PREDICT: A Method for Inferring Novel Drug Indications With Application to Personalized Medicine.” Molecular Systems Biology 7, no. 1: 496.
Guo, M., G. Kalra, W. Wilson, Y. Peng, and L. L. Augsburger. 2002. “A Prototype Intelligent Hybrid System for Hard Gelatin Capsule Formulation Development.” Pharmaceutical Technology 6: 44–52.
Hammerstrom, D. 1993. “Working With Neural Networks.” IEEE Spectrum 30, no. 7: 46–53.
Hammett, L. P. 1937. “The Effect of Structure Upon the Reactions of Organic Compounds. Benzene Derivatives.” Journal of the American Chemical Society 59, no. 1: 96–103.
Handelman, G. S., H. K. Kok, R. V. Chandra, et al. 2019. “Peering Into the Black Box of Artificial Intelligence: Evaluation Metrics of Machine Learning Methods.” American Journal of Roentgenology 212, no. 1: 38–43.
Hansch, C., and T. Fujita. 1964. “P‐σ‐π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure.” Journal of the American Chemical Society 86, no. 8: 1616–1626.
Harrer, S., P. Shah, B. Antony, and J. Hu. 2019. “Artificial Intelligence for Clinical Trial Design.” Trends in Pharmacological Sciences 40, no. 8: 577–591.
Hassanzadeh, P., F. Atyabi, and R. Dinarvand. 2019. “The Significance of Artificial Intelligence in Drug Delivery System Design.” Advanced Drug Delivery Reviews 151: 169–190.
Hearst, M. A., S. T. Dumais, E. Osuna, J. Platt, and B. Scholkopf. 1998. “Support Vector Machines.” IEEE Intelligent Systems and Their Applications 13, no. 4: 18–28.
Hegelich, S. 2023. “Defining Machine Learning.” In Digital Phenotyping and Mobile Sensing, 455–460. GmbH, Germany: Springer.
Hekkelman, M. L., I. de Vries, R. P. Joosten, and A. Perrakis. 2023. “AlphaFill: Enriching AlphaFold Models With Ligands and Cofactors.” Nature Methods 20, no. 2: 205–213. https://doi.org/10.1038/s41592‐022‐01685‐y.
Ho, T. K. 1995. “Random Decision Forests.” Paper Presented at the Proceedings of 3rd International Conference on Document Analysis and Recognition.
Hou, T., W. Zhang, D. A. Case, and W. Wang. 2008. “Characterization of Domain–Peptide Interaction Interface: A Case Study on the Amphiphysin‐1 SH3 Domain.” Journal of Molecular Biology 376, no. 4: 1201–1214.
Howard, J. 2019. “Artificial Intelligence: Implications for the Future of Work.” American Journal of Industrial Medicine 62, no. 11: 917–926.
Huang, Q., L.‐L. Li, and S.‐Y. Yang. 2011. “RASA: A Rapid Retrosynthesis‐Based Scoring Method for the Assessment of Synthetic Accessibility of Drug‐Like Molecules.” Journal of Chemical Information and Modeling 51: 2768–2777.
Hurle, M. R., L. Yang, Q. Xie, D. K. Rajpal, P. Sanseau, and P. Agarwal. 2013. “Computational Drug Repositioning: From Data to Therapeutics.” Clinical Pharmacology & Therapeutics 93, no. 4: 335–341.
Iorio, F., R. Bosotti, E. Scacheri, et al. 2010. “Discovery of Drug Mode of Action and Drug Repositioning From Transcriptional Responses.” Proceedings of the National Academy of Sciences of the United States of America 107, no. 33: 14621–14626.
Iorio, F., R. L. Shrestha, N. Levin, et al. 2015. “A Semi‐Supervised Approach for Refining Transcriptional Signatures of Drug Response and Repositioning Predictions.” PLoS One 10, no. 10: e0139446.
Jafarzadeh, A., M. Nemati, and S. Jafarzadeh. 2021. “Contribution of STAT3 to the Pathogenesis of COVID‐19.” Microbial Pathogenesis 154: 104836.
Jalkala, A. M., and J. Keränen. 2014. “Brand Positioning Strategies for Industrial Firms Providing Customer Solutions.” Journal of Business & Industrial Marketing 29: 253–264.
Janiesch, C., P. Zschech, and K. Heinrich. 2021. “Machine Learning and Deep Learning.” Electronic Markets 31, no. 3: 685–695.
Jimenez‐Carretero, D., V. Abrishami, L. Fernandez‐de‐Manuel, et al. 2018. “Tox_ (R) CNN: Deep Learning‐Based Nuclei Profiling Tool for Drug Toxicity Screening.” PLoS Computational Biology 14, no. 11: e1006238.
Johnson, K. B., W. Q. Wei, D. Weeraratne, et al. 2021. “Precision Medicine, AI, and the Future of Personalized Health Care.” Clinical and Translational Science 14, no. 1: 86–93.
Jordan, M. I., and T. M. Mitchell. 2015. “Machine Learning: Trends, Perspectives, and Prospects.” Science 349, no. 6245: 255–260.
Jumper, J., R. Evans, A. Pritzel, et al. 2021. “Highly Accurate Protein Structure Prediction With AlphaFold.” Nature 596, no. 7873: 583–589. https://doi.org/10.1038/s41586‐021‐03819‐2.
Kalafatis, S. P., M. H. Tsogas, and C. Blankson. 2000. “Positioning Strategies in Business Markets.” Journal of Business & Industrial Marketing 15: 416–437.
Kalra, G., Y. Peng, M. Guo, and L. L. Augsburger. 2002. “A Hybrid Intelligent System for Formulation of BCS Class II Drugs in Hard Gelatin Capsules.” Paper Presented at the Proceedings of the 9th International Conference on Neural Information Processing, 2002. ICONIP'02.
Kerru, N., S. V. Bhaskaruni, L. Gummidi, S. N. Maddila, S. Maddila, and S. B. Jonnalagadda. 2019. “Recent Advances in Heterogeneous Catalysts for the Synthesis of Imidazole Derivatives.” Synthetic Communications 49, no. 19: 2437–2459.
Ketterhagen, W. R., M. T. Am Ende, and B. C. Hancock. 2009. “Process Modeling in the Pharmaceutical Industry Using the Discrete Element Method.” Journal of Pharmaceutical Sciences 98, no. 2: 442–470.
Khurana, D., A. Koli, K. Khatter, and S. Singh. 2023. “Natural Language Processing: State of the Art, Current Trends and Challenges.” Multimedia Tools and Applications 82, no. 3: 3713–3744.
King, R. D., J. D. Hirst, and M. J. Sternberg. 1995. “Comparison of Artificial Intelligence Methods for Modeling Pharmaceutical QSARS.” Applied Artificial Intelligence an International Journal 9, no. 2: 213–233.
Krogh, A. 2008. “What Are Artificial Neural Networks?” Nature Biotechnology 26, no. 2: 195–197.
Kumar, A., S. Vembu, A. K. Menon, and C. Elkan. 2013. “Beam Search Algorithms for Multilabel Learning.” Machine Learning 92: 65–89.
Kumar, B., A. Thakur, A. R. Dwivedi, R. Kumar, and V. Kumar. 2022. “Multi‐Target‐Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease.” Current Medicinal Chemistry 29, no. 10: 1757–1803.
Lai, S. 1996. “An Expert System to Aid the Development of Capsule Formulations.” Pharmaceutical Technology Europe 8: 60–68.
Law, J., Z. Zsoldos, A. Simon, et al. 2009. “Route Designer: A Retrosynthetic Analysis Tool Utilizing Automated Retrosynthetic Rule Generation.” Journal of Chemical Information and Modeling 49, no. 3: 593–602.
LeCun, Y., Y. Bengio, and G. Hinton. 2015. “Deep Learning.” Nature 521, no. 7553: 436–444.
Liu, G., D. B. Catacutan, K. Rathod, et al. 2023. “Deep Learning‐Guided Discovery of an Antibiotic Targeting Acinetobacter baumannii.” Nature Chemical Biology 19: 1–9.
Liu, T., M. Naderi, C. Alvin, S. Mukhopadhyay, and M. Brylinski. 2017. “Break Down in Order to Build Up: Decomposing Small Molecules for Fragment‐Based Drug Design With eMolFrag.” Journal of Chemical Information and Modeling 57, no. 4: 627–631.
Liu, X., S. C. Rivera, D. Moher, M. J. Calvert, and A. K. Denniston. 2020. “Reporting Guidelines for Clinical Trial Reports for Interventions Involving Artificial Intelligence: The CONSORT‐AI Extension.” BMJ 2, no. 10: e537–e548.
Liu, X., C. Shi, U. Deore, et al. 2021. “A Scalable AI Approach for Clinical Trial Cohort Optimization.” Paper Presented at the Joint European Conference on Machine Learning and Knowledge Discovery in Databases.
Lounkine, E., M. J. Keiser, S. Whitebread, et al. 2012. “Large‐Scale Prediction and Testing of Drug Activity on Side‐Effect Targets.” Nature 486, no. 7403: 361–367.
Luo, M., Y. Feng, T. Wang, and J. Guan. 2018. “Micro‐/Nanorobots at Work in Active Drug Delivery.” Advanced Functional Materials 28, no. 25: 1706100.
Luo, Y., X. Zhao, J. Zhou, et al. 2017. “A Network Integration Approach for Drug–Target Interaction Prediction and Computational Drug Repositioning From Heterogeneous Information.” Nature Communications 8, no. 1: 1–13.
Lusci, A., G. Pollastri, and P. Baldi. 2013. “Deep Architectures and Deep Learning in Chemoinformatics: The Prediction of Aqueous Solubility for Drug‐Like Molecules.” Journal of Chemical Information and Modeling 53, no. 7: 1563–1575.
Mak, K.‐K., and M. R. Pichika. 2019. “Artificial Intelligence in Drug Development: Present Status and Future Prospects.” Drug Discovery Today 24, no. 3: 773–780.
Mamoshina, P., A. Vieira, E. Putin, and A. Zhavoronkov. 2016. “Applications of Deep Learning in Biomedicine.” Molecular Pharmaceutics 13, no. 5: 1445–1454.
Mao, J., J. Wang, A. Zeb, et al. 2023. “Transformer‐Based Molecular Generative Model for Antiviral Drug Design.” Journal of Chemical Information and Modeling 64, no. 7: 2733–2745.
Marr, B. 2018. “How Is AI Used in Education—Real World Examples of Today and a Peek Into the Future.” Forbes Magazine 25.
Martin, E. J., V. R. Polyakov, L. Tian, and R. C. Perez. 2017. “Profile‐QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four‐Concentration IC50s for Realistically Novel Compounds.” Journal of Chemical Information and Modeling 57, no. 8: 2077–2088.
Martinelli, D. D. 2022. “Generative Machine Learning for De Novo Drug Discovery: A Systematic Review.” Computers in Biology and Medicine 145: 105403.
Marvin, M., and A. P. Seymour. 1969. Perceptrons. Vol. 6, 318–362. Cambridge, MA: MIT Press.
Mayr, A., G. Klambauer, T. Unterthiner, and S. Hochreiter. 2016. “DeepTox: Toxicity Prediction Using Deep Learning.” Frontiers in Environmental Science 3: 80.
McCulloch, W. S., and W. Pitts. 1943. “A Logical Calculus of the Ideas Immanent in Nervous Activity.” Bulletin of Mathematical Biophysics 5, no. 4: 115–133.
McInerney, C. E., J. A. Lynn, A. R. Gilmore, T. Flannery, and K. M. Prise. 2022. “Using AI‐Based Evolutionary Algorithms to Elucidate Adult Brain Tumor (Glioma) Etiology Associated With IDH1 for Therapeutic Target Identification.” Current Issues in Molecular Biology 44, no. 7: 2982–3000.
Mehta, C. H., R. Narayan, and U. Y. Nayak. 2019. “Computational Modeling for Formulation Design.” Drug Discovery Today 24, no. 3: 781–788.
Mei, J.‐P., C.‐K. Kwoh, P. Yang, X.‐L. Li, and J. Zheng. 2013. “Drug–Target Interaction Prediction by Learning From Local Information and Neighbors.” Bioinformatics 29, no. 2: 238–245.
Mintz, Y., and R. Brodie. 2019. “Introduction to Artificial Intelligence in Medicine.” Minimally Invasive Therapy & Allied Technologies 28, no. 2: 73–81.
Mitchell, T. M., and T. M. Mitchell. 1997. Machine Learning. Vol. 1. New York: McGraw‐Hill.
Mohapatra, B. N., and P. P. Panda. 2019. “Machine Learning Applications to Smart City.” ACCENTS Transactions on Image Processing and Computer Vision 5, no. 14: 1–6.
Naderi, M., C. Alvin, Y. Ding, S. Mukhopadhyay, and M. Brylinski. 2016. “A Graph‐Based Approach to Construct Target‐Focused Libraries for Virtual Screening.” Journal of Cheminformatics 8: 1–16.
Nadkarni, P. M., L. Ohno‐Machado, and W. W. Chapman. 2011. “Natural Language Processing: An Introduction.” Journal of the American Medical Informatics Association 18, no. 5: 544–551.
Nussinov, R., M. Zhang, Y. Liu, and H. Jang. 2023. “AlphaFold, Allosteric, and Orthosteric Drug Discovery: Ways Forward.” Drug Discovery Today 28, no. 6: 103551. https://doi.org/10.1016/j.drudis.2023.103551.
Ourmazd, A., K. Moffat, and E. E. Lattman. 2022. “Structural Biology Is Solved—Now What?” Nature Methods 19, no. 1: 24–26. https://doi.org/10.1038/s41592‐021‐01357‐3.
Padlipsky, M. A. 1982. “Perspective on the ARPANET Reference Model (2070‐1721).” rfc871.
Paloque‐Bergès, C., and V. Schafer. 2019. “Arpanet (1969–2019).” Internet Histories 3, no. 1: 1–14.
Patil, V. M., N. Masand, S. Verma, and V. Masand. 2021. “Chromones: Privileged Scaffold in Anticancer Drug Discovery.” Chemical Biology & Drug Design 98, no. 5: 943–953.
Patlewicz, G., N. Jeliazkova, R. Safford, A. Worth, and B. Aleksiev. 2008. “An Evaluation of the Implementation of the Cramer Classification Scheme in the Toxtree Software.” SAR and QSAR in Environmental Research 19, no. 5–6: 495–524.
Paul, D., G. Sanap, S. Shenoy, D. Kalyane, K. Kalia, and R. K. Tekade. 2021. “Artificial Intelligence in Drug Discovery and Development.” Drug Discovery Today 26, no. 1: 80–93.
Pedretti, A., A. Mazzolari, S. Gervasoni, and G. Vistoli. 2020. “Tree2C: A Flexible Tool for Enabling Model Deployment With Special Focus on Cheminformatics Applications.” Applied Sciences 10, no. 21: 7704.
Pereira, J. C., E. R. Caffarena, and C. N. Dos Santos. 2016. “Boosting Docking‐Based Virtual Screening With Deep Learning.” Journal of Chemical Information and Modeling 56, no. 12: 2495–2506.
Perrakis, A., and T. K. Sixma. 2021. “AI Revolutions in Biology.” EMBO Reports 22, no. 11: e54046. https://doi.org/10.15252/embr.202154046.
Pfeifer, R., and F. Iida. 2004. “Embodied Artificial Intelligence: Trends and Challenges.” Embodied Artificial Intelligence, 1–26. International Seminar, Dagstuhl Castle, Germany, July 7‐11, 2003.
Popova, M., O. Isayev, and A. Tropsha. 2018. “Deep Reinforcement Learning for De Novo Drug Design.” Science Advances 4, no. 7: eaap7885.
Prakash, C., R. Kumar, and N. Mittal. 2018. “Recent Developments in Human Gait Research: Parameters, Approaches, Applications, Machine Learning Techniques, Datasets and Challenges.” Artificial Intelligence Review 49, no. 1: 1–40.
Pu, L., M. Naderi, T. Liu, H.‐C. Wu, S. Mukhopadhyay, and M. Brylinski. 2019. “eToxPred: A Machine Learning‐Based Approach to Estimate the Toxicity of Drug Candidates.” BMC Pharmacology and Toxicology 20: 1–15.
Putin, E., A. Asadulaev, Y. Ivanenkov, et al. 2018. “Reinforced Adversarial Neural Computer for De Novo Molecular Design.” Journal of Chemical Information and Modeling 58, no. 6: 1194–1204.
Rantanen, J., and J. Khinast. 2015. “The Future of Pharmaceutical Manufacturing Sciences.” Journal of Pharmaceutical Sciences 104, no. 11: 3612–3638.
Reddy, A. S., and S. Zhang. 2013. “Polypharmacology: Drug Discovery for the Future.” Expert Review of Clinical Pharmacology 6, no. 1: 41–47.
Reiter, E., and R. Dale. 1997. “Building Applied Natural Language Generation Systems.” Natural Language Engineering 3, no. 1: 57–87.
Reymond, J.‐L., R. Van Deursen, L. C. Blum, and L. Ruddigkeit. 2010. “Chemical Space as a Source for New Drugs.” MedChemComm 1, no. 1: 30–38.
Richardson, P., I. Griffin, C. Tucker, et al. 2020. “Baricitinib as Potential Treatment for 2019‐nCoV Acute Respiratory Disease.” Lancet 395, no. 10223: e30–e31.
Riesterer, N., D. Brand, and M. Ragni. 2020. “Predictive Modeling of Individual Human Cognition: Upper Bounds and a New Perspective on Performance.” Topics in Cognitive Science 12, no. 3: 960–974.
Rivera, S. C., X. Liu, A.‐W. Chan, et al. 2020. “Guidelines for Clinical Trial Protocols for Interventions Involving Artificial Intelligence: The SPIRIT‐AI Extension.” Lancet Digital Health 2, no. 10: e549–e560.
Rodgers, W., J. M. Murray, A. Stefanidis, W. Y. Degbey, and S. Y. Tarba. 2023. “An Artificial Intelligence Algorithmic Approach to Ethical Decision‐Making in Human Resource Management Processes.” Human Resource Management Review 33, no. 1: 100925.
Roy, R., and H. M. Al‐Hashimi. 2024. “AlphaFold3 Takes a Step Toward Decoding Molecular Behavior and Biological Computation.” Nature Structural & Molecular Biology 31, no. 7: 997–1000. https://doi.org/10.1038/s41594‐024‐01350‐2.
Rupp, M., and G. Schneider. 2010. “Graph Kernels for Molecular Similarity.” Molecular Informatics 29, no. 4: 266–273.
Ryu, J. Y., H. U. Kim, and S. Y. Lee. 2018. “Deep Learning Improves Prediction of Drug–Drug and Drug–Food Interactions.” Proceedings of the National Academy of Sciences of the United States of America 115, no. 18: E4304–E4311.
Schank, R. C. 1972. “Conceptual Dependency: A Theory of Natural Language Understanding.” Cognitive Psychology 3, no. 4: 552–631.
Schmidt, J., M. R. G. Marques, S. Botti, and M. A. L. Marques. 2019. “Recent Advances and Applications of Machine Learning in Solid‐State Materials Science.” Npj Computational Materials 5, no. 1: 83. https://doi.org/10.1038/s41524‐019‐0221‐0.
Schneider, G. 2018. “Automating Drug Discovery.” Nature Reviews Drug Discovery 17, no. 2: 97–113.
Schneider, P., W. P. Walters, A. T. Plowright, et al. 2020. “Rethinking Drug Design in the Artificial Intelligence Era.” Nature Reviews Drug Discovery 19, no. 5: 353–364.
Seddon, G., V. Lounnas, R. McGuire, et al. 2012. “Drug Design for Ever, From Hype to Hope.” Journal of Computer‐Aided Molecular Design 26, no. 1: 137–150.
Segler, M. H., T. Kogej, C. Tyrchan, and M. P. Waller. 2018. “Generating Focused Molecule Libraries for Drug Discovery With Recurrent Neural Networks.” ACS Central Science 4, no. 1: 120–131.
Segler, M. H., M. Preuss, and M. P. Waller. 2018. “Planning Chemical Syntheses With Deep Neural Networks and Symbolic AI.” Nature 555, no. 7698: 604–610.
Sharma, V., S. Rai, and A. Dev. 2012. “A Comprehensive Study of Artificial Neural Networks.” International Journal of Advanced Research in Computer Science and Software Engineering 2, no. 10: 278–284.
Shaw, G. L. 1986. “Donald Hebb: The Organization of Behavior.” In Brain Theory, 231–233. New York, NY: Springer.
Signorelli, C. M. 2018. “Can Computers Become Conscious and Overcome Humans?” Frontiers in Robotics and AI 5: 121. https://doi.org/10.3389/frobt.2018.00121.
Singh, A., G. Madaan, H. Swapna, and A. Kumar. 2023. “Impact of Artificial Intelligence on Human Capital in Healthcare Sector Post‐COVID‐19.” In The Adoption and Effect of Artificial Intelligence on Human Resources Management, Part A, 47–69. Leeds, England: Emerald Publishing Limited.
Singh, Y., P. K. Bhatia, and O. Sangwan. 2007. “A Review of Studies on Machine Learning Techniques.” International Journal of Computer Science and Security 1, no. 1: 70–84.
Skayneh, H., B. Jishi, R. Hleihel, et al. 2022. “EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML.” International Journal of Molecular Sciences 23, no. 7: 3421.
Sollini, M., F. Bartoli, A. Marciano, R. Zanca, R. H. Slart, and P. A. Erba. 2020. “Artificial Intelligence and Hybrid Imaging: The Best Match for Personalized Medicine in Oncology.” European Journal of Hybrid Imaging 4, no. 1: 1–22.
Struble, T. J., J. C. Alvarez, S. P. Brown, et al. 2020. “Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis.” Journal of Medicinal Chemistry 63, no. 16: 8667–8682.
Sun, H., P. Pan, S. Tian, et al. 2016. “Constructing and Validating High‐Performance MIEC‐SVM Models in Virtual Screening for Kinases: A Better Way for Actives Discovery.” Scientific Reports 6, no. 1: 1–12.
Sutton, R. S. 1992. “Introduction: The Challenge of Reinforcement Learning.” In Reinforcement Learning, 1–3. Boston, MA: Springer.
Szklarczyk, D., A. L. Gable, D. Lyon, et al. 2019. “STRING v11: Protein–Protein Association Networks With Increased Coverage, Supporting Functional Discovery in Genome‐Wide Experimental Datasets.” Nucleic Acids Research 47, no. D1: D607–D613.
Szymkuć, S., E. P. Gajewska, T. Klucznik, et al. 2016. “Computer‐Assisted Synthetic Planning: The End of the Beginning.” Angewandte Chemie International Edition 55, no. 20: 5904–5937.
Takigawa, I., and H. Mamitsuka. 2013. “Graph Mining: Procedure, Application to Drug Discovery and Recent Advances.” Drug Discovery Today 18, no. 1–2: 50–57.
Tan, B. K. J., C. B. Teo, X. Tadeo, et al. 2021. “Personalised, Rational, Efficacy‐Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE. AI Pilot Clinical Trial.” Frontiers in Digital Health 3: 635524.
Tetko, I. V. 2002. “Associative Neural Network.” Neural Processing Letters 16, no. 2: 187–199.
Thompson, W. R., A. J. Reinisch, M. J. Unterberger, and A. J. Schriefl. 2019. “Artificial Intelligence‐Assisted Auscultation of Heart Murmurs: Validation by Virtual Clinical Trial.” Pediatric Cardiology 40, no. 3: 623–629.
Tiwari, P. C., R. Pal, M. J. Chaudhary, and R. Nath. 2023. “Artificial Intelligence Revolutionizing Drug Development: Exploring Opportunities and Challenges.” Drug Development Research 84: 1652–1663.
Tucker, A. B. 2004. Computer Science Handbook. Florida: Chapman and Hall/CRC.
Villaverde, J. E., D. Godoy, and A. Amandi. 2006. “Learning Styles' Recognition in e‐Learning Environments With Feed‐Forward Neural Networks.” Journal of Computer Assisted Learning 22, no. 3: 197–206.
Voulodimos, A., N. Doulamis, A. Doulamis, and E. Protopapadakis. 2018. “Deep Learning for Computer Vision: A Brief Review.” Computational Intelligence and Neuroscience 2018: 7068349. https://doi.org/10.1155/2018/7068349.
Wachsmuth, I. 2000. “The Concept of Intelligence in AI.” In Prerational Intelligence: Adaptive Behavior and Intelligent Systems Without Symbols and Logic, Volume 1, Volume 2 Prerational Intelligence: Interdisciplinary Perspectives on the Behavior of Natural and Artificial Systems, Volume 3, 43–55. Dordrecht: Springer.
Wang, F., D. Liu, H. Wang, et al. 2011. “Computational Screening for Active Compounds Targeting Protein Sequences: Methodology and Experimental Validation.” Journal of Chemical Information and Modeling 51, no. 11: 2821–2828.
Wang, M., Y. Cui, X. Wang, S. Xiao, and J. Jiang. 2017. “Machine Learning for Networking: Workflow, Advances and Opportunities.” IEEE Network 32, no. 2: 92–99.
Wang, Q., Y. Feng, J. Huang, T. Wang, and G. Cheng. 2017. “A Novel Framework for the Identification of Drug Target Proteins: Combining Stacked Auto‐Encoders With a Biased Support Vector Machine.” PLoS One 12, no. 4: e0176486.
Wang, X., S. Allen, J. F. Blake, et al. 2022. “Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor.” Journal of Medicinal Chemistry 65, no. 4: 3123–3133. https://doi.org/10.1021/acs.jmedchem.1c01688.
Waqas, A., A. R. Gilal, Z. Bhatti, and A. W. Mahessar. 2013. “Investigating ANNs and Applications.” Indian Journal of Automation and Artificial Intelligence 1, no. 2: 65–69.
Wei, J. N., D. Duvenaud, and A. Aspuru‐Guzik. 2016. “Neural Networks for the Prediction of Organic Chemistry Reactions.” ACS Central Science 2, no. 10: 725–732.
Weinstein, J. N., K. W. Kohn, M. R. Grever, et al. 1992. “Neural Computing in Cancer Drug Development: Predicting Mechanism of Action.” Science 258, no. 5081: 447–451.
Weissler, E. H., T. Naumann, T. Andersson, et al. 2021. “The Role of Machine Learning in Clinical Research: Transforming the Future of Evidence Generation.” Trials 22, no. 1: 1–15.
Wessel, M. D., P. C. Jurs, J. W. Tolan, and S. M. Muskal. 1998. “Prediction of Human Intestinal Absorption of Drug Compounds From Molecular Structure.” Journal of Chemical Information and Computer Sciences 38, no. 4: 726–735.
Wilkinson, J., K. F. Arnold, E. J. Murray, et al. 2020. “Time to Reality Check the Promises of Machine Learning‐Powered Precision Medicine.” Lancet Digital Health 2, no. 12: e677–e680.
World Health Organization. 2021. Ethics and Governance of Artificial Intelligence for Health: WHO Guidance. Geneva, Switzerland: World Health Organization.
Xia, Z., L.‐Y. Wu, X. Zhou, and S. T. Wong. 2010. “Semi‐Supervised Drug–Protein Interaction Prediction From Heterogeneous Biological Spaces.” Paper Presented at the BMC Systems Biology.
Xiao, X., J.‐L. Min, W.‐Z. Lin, Z. Liu, X. Cheng, and K.‐C. Chou. 2015. “iDrug‐Target: Predicting the Interactions Between Drug Compounds and Target Proteins in Cellular Networking via Benchmark Dataset Optimization Approach.” Journal of Biomolecular Structure and Dynamics 33, no. 10: 2221–2233.
Xiong, Y., Y. Wang, Y. Wang, et al. 2023. “Improving Drug Discovery With a Hybrid Deep Generative Model Using Reinforcement Learning Trained on a Bayesian Docking Approximation.” Journal of Computer‐Aided Molecular Design 37: 1–11.
Xu, Y., J. Pei, and L. Lai. 2017. “Deep Learning Based Regression and Multiclass Models for Acute Oral Toxicity Prediction With Automatic Chemical Feature Extraction.” Journal of Chemical Information and Modeling 57, no. 11: 2672–2685.
Yampolskiy, R. V. 2019. “Predicting Future AI Failures From Historic Examples.” Foresight 21, no. 1: 138–152.
Yan, X.‐Y., S.‐W. Zhang, and S.‐Y. Zhang. 2016. “Prediction of Drug–Target Interaction by Label Propagation With Mutual Interaction Information Derived From Heterogeneous Network.” Molecular BioSystems 12, no. 2: 520–531.
Yan, Y., W. Wang, Z. Sun, J. Z. Zhang, and C. Ji. 2017. “Protein–Ligand Empirical Interaction Components for Virtual Screening.” Journal of Chemical Information and Modeling 57, no. 8: 1793–1806.
Yang, X., Y. Wang, R. Byrne, G. Schneider, and S. Yang. 2019. “Concepts of Artificial Intelligence for Computer‐Assisted Drug Discovery.” Chemical Reviews 119, no. 18: 10520–10594.
Yu, H., J. Chen, X. Xu, et al. 2012. “A Systematic Prediction of Multiple Drug–Target Interactions From Chemical, Genomic, and Pharmacological Data.” PLoS One 7, no. 5: e37608.
Zang, Q., K. Mansouri, A. J. Williams, et al. 2017. “In Silico Prediction of Physicochemical Properties of Environmental Chemicals Using Molecular Fingerprints and Machine Learning.” Journal of Chemical Information and Modeling 57, no. 1: 36–49.
Zarrinpar, A., D.‐K. Lee, A. Silva, et al. 2016. “Individualizing Liver Transplant Immunosuppression Using a Phenotypic Personalized Medicine Platform.” Science Translational Medicine 8, no. 333: 333ra349.
Zeng, X., S. Zhu, W. Lu, et al. 2020. “Target Identification Among Known Drugs by Deep Learning From Heterogeneous Networks.” Chemical Science 11, no. 7: 1775–1797.
Zhang, C., and Y. Lu. 2021. “Study on Artificial Intelligence: The State of the Art and Future Prospects.” Journal of Industrial Information Integration 23: 100224.
Zhang, L., J. Tan, D. Han, and H. Zhu. 2017. “From Machine Learning to Deep Learning: Progress in Machine Intelligence for Rational Drug Discovery.” Drug Discovery Today 22, no. 11: 1680–1685.
Zhang, P., P. Agarwal, and Z. Obradovic. 2013. “Computational Drug Repositioning by Ranking and Integrating Multiple Data Sources.” Paper Presented at the Joint European Conference on Machine Learning and Knowledge Discovery in Databases.
Zhao, C., A. Jain, L. Hailemariam, et al. 2006. “Toward Intelligent Decision Support for Pharmaceutical Product Development.” Journal of Pharmaceutical Innovation 1, no. 1: 23–35.
Zhou, T., S. Jhamb, X. Liang, K. Sundmacher, and R. Gani. 2018. “Prediction of Acid Dissociation Constants of Organic Compounds Using Group Contribution Methods.” Chemical Engineering Science 183: 95–105.
Zhuang, D., and A. K. Ibrahim. 2021. “Deep Learning for Drug Discovery: A Study of Identifying High Efficacy Drug Compounds Using a Cascade Transfer Learning Approach.” Applied Sciences 11, no. 17: 7772.
Abramson, J., J. Adler, J. Dunger, et al. 2024. “Accurate Structure Prediction of Biomolecular Interactions With AlphaFold 3.” Nature 630, no. 8016: 493–500. https://doi.org/10.1038/s41586‐024‐07487‐w.
Achenbach, J., P. Tiikkainen, L. Franke, and E. Proschak. 2011. “Computational Tools for Polypharmacology and Repurposing.” Future Medicinal Chemistry 3, no. 8: 961–968.
Aksu, B., A. Paradkar, M. de Matas, Ö. Özer, T. Güneri, and P. York. 2013. “A Quality by Design Approach Using Artificial Intelligence Techniques to Control the Critical Quality Attributes of Ramipril Tablets Manufactured by Wet Granulation.” Pharmaceutical Development and Technology 18, no. 1: 236–245.
Alaloul, W. S., and A. H. Qureshi. 2020. “Data Processing Using Artificial Neural Networks.” Dynamic Data Assimilation‐Beating the Uncertainties. https://dx.doi.org/10.5772/intechopen.91935.
Al‐Faris, M., J. Chiverton, D. Ndzi, and A. I. Ahmed. 2020. “A Review on Computer Vision‐Based Methods for Human Action Recognition.” Journal of Imaging 6, no. 6: 46. https://doi.org/10.3390/jimaging6060046.
Álvarez‐Machancoses, Ó., and J. L. Fernández‐Martínez. 2019. “Using Artificial Intelligence Methods to Speed Up Drug Discovery.” Expert Opinion on Drug Discovery 14, no. 8: 769–777.
Ammari, M. G., C. R. Gresham, F. M. McCarthy, and B. Nanduri. 2016. “HPIDB 2.0: A Curated Database for Host–Pathogen Interactions.” Database 2016: baw103.
Anderson, J. A. 1995. An Introduction to Neural Networks. Cambridge, MA: MIT Press.
Baek, M., F. DiMaio, I. Anishchenko, et al. 2021. “Accurate Prediction of Protein Structures and Interactions Using a Three‐Track Neural Network.” Science 373, no. 6557: 871–876. https://doi.org/10.1126/science.abj8754.
Bai, Q., S. Tan, T. Xu, H. Liu, J. Huang, and X. Yao. 2021. “MolAICal: A Soft Tool for 3D Drug Design of Protein Targets by Artificial Intelligence and Classical Algorithm.” Briefings in Bioinformatics 22, no. 3: bbaa161.
Bajorath, J. 2023. “Generative Kinase Inhibitor Modeling Viewed From a Medicinal Chemistry Perspective.” Future Medicinal Chemistry 15, no. 4: 313–315.
Bajorath, J., S. Kearnes, W. P. Walters, N. A. Meanwell, G. I. Georg, and S. Wang. 2020. “Artificial Intelligence in Drug Discovery: Into the Great Wide Open.” Journal of Medicinal Chemistry 63, no. 16: 8651–8652. https://doi.org/10.1021/acs.jmedchem.0c01077.
Bakkar, N., T. Kovalik, I. Lorenzini, et al. 2018. “Artificial Intelligence in Neurodegenerative Disease Research: Use of IBM Watson to Identify Additional RNA‐Binding Proteins Altered in Amyotrophic Lateral Sclerosis.” Acta Neuropathologica 135, no. 2: 227–247.
Bannigan, P., M. Aldeghi, Z. Bao, F. Häse, A. Aspuru‐Guzik, and C. Allen. 2021. “Machine Learning Directed Drug Formulation Development.” Advanced Drug Delivery Reviews 175: 113806.
Basile, A. O., A. Yahi, and N. P. Tatonetti. 2019. “Artificial Intelligence for Drug Toxicity and Safety.” Trends in Pharmacological Sciences 40, no. 9: 624–635.
Bateman, J., and M. Zock. 2003. “Natural Language Generation.” In The Oxford Handbook of Computational Linguistics, edited by R. Mitkov. Oxford, UK: Oxford Academic.
Bates, M. 1995. “Models of Natural Language Understanding.” Proceedings of the National Academy of Sciences of the United States of America 92, no. 22: 9977–9982.
Belkin, M., P. Niyogi, and V. Sindhwani. 2006. “Manifold Regularization: A Geometric Framework for Learning From Labeled and Unlabeled Examples.” Journal of Machine Learning Research 7, no. 11: 2399–2434.
Bertinetto, L., J. Valmadre, J. F. Henriques, A. Vedaldi, and P. H. Torr. 2016. “Fully‐Convolutional Siamese Networks for Object Tracking.” Paper Presented at the Computer Vision‐ECCV 2016 Workshops: Amsterdam, The Netherlands, October 8–10 and 15–16, 2016, Proceedings, Part II 14.
Besnard, J., G. F. Ruda, V. Setola, et al. 2012. “Automated Design of Ligands to Polypharmacological Profiles.” Nature 492, no. 7428: 215–220.
Bess, A., F. Berglind, S. Mukhopadhyay, et al. 2022. “Artificial Intelligence for the Discovery of Novel Antimicrobial Agents for Emerging Infectious Diseases.” Drug Discovery Today 27, no. 4: 1099–1107.
Bhirde, A. A., M.‐J. Chiang, R. Venna, S. Beaucage, and K. Brorson. 2018. “High‐Throughput In‐Use and Stress Size Stability Screening of Protein Therapeutics Using Algorithm‐Driven Dynamic Light Scattering.” Journal of Pharmaceutical Sciences 107, no. 8: 2055–2062.
Bishop, C. M. 1994. “Neural Networks and Their Applications.” Review of Scientific Instruments 65, no. 6: 1803–1832.
Bishop, C. M., and N. M. Nasrabadi. 2006. Pattern Recognition and Machine Learning. Vol. 4. New York: Springer.
Blasiak, A., J. Khong, and T. Kee. 2020. “CURATE. AI: Optimizing Personalized Medicine With Artificial Intelligence.” SLAS Technology 25, no. 2: 95–105.
Cañada, A., S. Capella‐Gutierrez, O. Rabal, J. Oyarzabal, A. Valencia, and M. Krallinger. 2017. “LimTox: A Web Tool for Applied Text Mining of Adverse Event and Toxicity Associations of Compounds, Drugs and Genes.” Nucleic Acids Research 45, no. W1: W484–W489.
Carrella, D., F. Napolitano, R. Rispoli, et al. 2014. “Mantra 2.0: An Online Collaborative Resource for Drug Mode of Action and Repurposing by Network Analysis.” Bioinformatics 30, no. 12: 1787–1788.
Chai, J., H. Zeng, A. Li, and E. W. T. Ngai. 2021. “Deep Learning in Computer Vision: A Critical Review of Emerging Techniques and Application Scenarios.” Machine Learning with Applications 6: 100134. https://doi.org/10.1016/j.mlwa.2021.100134.
Chakraborty, S., S. K. Islam, and D. Samanta. 2022. “A Brief Concept on Machine Learning.” In Data Classification and Incremental Clustering in Data Mining and Machine Learning, 23–32. Germany: Springer.
Chan, H. S., H. Shan, T. Dahoun, H. Vogel, and S. Yuan. 2019. “Advancing Drug Discovery via Artificial Intelligence.” Trends in Pharmacological Sciences 40, no. 8: 592–604.
Chen, H., and Z. Zhang. 2013. “A Semi‐Supervised Method for Drug–Target Interaction Prediction With Consistency in Networks.” PLoS One 8, no. 5: e62975.
Chen, J., Z. Wang, C.‐M. Li, et al. 2010. “Discovery of Novel 2‐Aryl‐4‐Benzoyl‐Imidazoles Targeting the Colchicines Binding Site in Tubulin as Potential Anticancer Agents.” Journal of Medicinal Chemistry 53, no. 20: 7414–7427.
Chen, J. J. F., and D. P. Visco Jr. 2017. “Developing an In Silico Pipeline for Faster Drug Candidate Discovery: Virtual High Throughput Screening With the Signature Molecular Descriptor Using Support Vector Machine Models.” Chemical Engineering Science 159: 31–42.
Chen, L., H. Deng, H. Cui, et al. 2018. “Inflammatory Responses and Inflammation‐Associated Diseases in Organs.” Oncotarget 9, no. 6: 7204–7218.
Chen, W., D. Desai, D. Good, et al. 2016. “Mathematical Model‐Based Accelerated Development of Extended‐Release Metformin Hydrochloride Tablet Formulation.” AAPS PharmSciTech 17, no. 4: 1007–1013.
Chen, X., D. Zou, H. Xie, G. Cheng, and C. Liu. 2022. “Two Decades of Artificial Intelligence in Education.” Educational Technology & Society 25, no. 1: 28–47.
Cheng, F., W. Li, Y. Zhou, et al. 2012. “admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties.” Journal of Chemical Information and Modeling 52, no. 11: 3099–3105.
Ching, T., D. S. Himmelstein, B. K. Beaulieu‐Jones, et al. 2018. “Opportunities and Obstacles for Deep Learning in Biology and Medicine.” Journal of the Royal Society Interface 15, no. 141: 20170387.
Chiu, C.‐Y., Y.‐F. Chen, I.‐T. Kuo, and H. C. Ku. 2009. “An Intelligent Market Segmentation System Using k‐Means and Particle Swarm Optimization.” Expert Systems with Applications 36, no. 3: 4558–4565.
Chowdhary, K. R. 2020. “Natural Language Processing.” In Fundamentals of Artificial Intelligence, 603–649. New Delhi: Springer. https://doi.org/10.1007/978‐81‐322‐3972‐7_19.
Cid Vidal, X., L. Dieste Maroñas, and Á. Dosil Suárez. 2022. “Modern Machine Learning: Applications and Methods.” In Machine Learning and Artificial Intelligence With Industrial Applications, 19–61. Cham, Switzerland: Springer.
Coleman, C. M., J. M. Sisk, R. M. Mingo, E. A. Nelson, J. M. White, and M. B. Frieman. 2016. “Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.” Journal of Virology 90, no. 19: 8924–8933.
Coley, C. W., R. Barzilay, W. H. Green, T. S. Jaakkola, and K. F. Jensen. 2017. “Convolutional Embedding of Attributed Molecular Graphs for Physical Property Prediction.” Journal of Chemical Information and Modeling 57, no. 8: 1757–1772.
Coley, C. W., R. Barzilay, T. S. Jaakkola, W. H. Green, and K. F. Jensen. 2017. “Prediction of Organic Reaction Outcomes Using Machine Learning.” ACS Central Science 3, no. 5: 434–443.
Coley, C. W., W. H. Green, and K. F. Jensen. 2019. “RDChiral: An RDKit Wrapper for Handling Stereochemistry in Retrosynthetic Template Extraction and Application.” Journal of Chemical Information and Modeling 59, no. 6: 2529–2537.
Collatuzzo, G., and P. Boffetta. 2022. “Application of P4 (Predictive, Preventive, Personalized, Participatory) Approach to Occupational Medicine.” La Medicina del Lavoro 113, no. 1: e2022009.
Collins, K. D., and F. Glorius. 2013. “A Robustness Screen for the Rapid Assessment of Chemical Reactions.” Nature Chemistry 5, no. 7: 597–601.
Colombo, S. 2020. “Applications of Artificial Intelligence in Drug Delivery and Pharmaceutical Development.” In Artificial Intelligence in Healthcare, 85–116. Massachusetts: Elsevier.
Dana, D., S. V. Gadhiya, L. G. St. Surin, et al. 2018. “Deep Learning in Drug Discovery and Medicine; Scratching the Surface.” Molecules 23, no. 9: 2384.
Das, B. R., D. Singh, P. C. Bhoi, and D. Mishra. 2021. “Role of Intelligent Techniques in Natural Language Processing: An Empirical Study.” In Intelligent and Cloud Computing, 481–490. Singapore: Springer.
de Almeida, A. F., R. Moreira, and T. Rodrigues. 2019. “Synthetic Organic Chemistry Driven by Artificial Intelligence.” Nature Reviews Chemistry 3, no. 10: 589–604.
Deiana, A. M., N. Tran, J. Agar, et al. 2022. “Applications and Techniques for Fast Machine Learning in Science.” Frontiers in Big Data 5: 787421.
Delso, G., D. Cirillo, J. D. Kaggie, A. Valencia, U. Metser, and P. Veit‐Haibach. 2021. “How to Design AI‐Driven Clinical Trials in Nuclear Medicine.” Paper Presented at the Seminars in Nuclear Medicine.
Dhall, D., R. Kaur, and M. Juneja. 2020. “Machine Learning: A Review of the Algorithms and Its Applications.” Proceedings of ICRIC 2019: 47–63.
Dong, S., P. Wang, and K. Abbas. 2021. “A Survey on Deep Learning and Its Applications.” Computer Science Review 40: 100379.
Drăgoi, E. N., S. Curteanu, and D. Fissore. 2013. “On the Use of Artificial Neural Networks to Monitor a Pharmaceutical Freeze‐Drying Process.” Drying Technology 31, no. 1: 72–81.
Drew, K., C. Lee, R. L. Huizar, et al. 2017. “Integration of Over 9,000 Mass Spectrometry Experiments Builds a Global Map of Human Protein Complexes.” Molecular Systems Biology 13, no. 6: 932.
Dudley, J. T., T. Deshpande, and A. J. Butte. 2011. “Exploiting Drug–Disease Relationships for Computational Drug Repositioning.” Briefings in Bioinformatics 12, no. 4: 303–311.
Fan, J., M. Campbell, and B. Kingsbury. 2011. “Artificial Intelligence Research at IBM.” IBM Journal of Research and Development 55, no. 5: 16:1–16:4.
Fang, X., S. Bagui, and S. Bagui. 2017. “Improving Virtual Screening Predictive Accuracy of Human Kallikrein 5 Inhibitors Using Machine Learning Models.” Computational Biology and Chemistry 69: 110–119.
Ferrero, E., I. Dunham, and P. Sanseau. 2017. “In Silico Prediction of Novel Therapeutic Targets Using Gene–Disease Association Data.” Journal of Translational Medicine 15, no. 1: 1–16.
Fialkowski, M., K. J. Bishop, V. A. Chubukov, C. J. Campbell, and B. A. Grzybowski. 2005. “Architecture and Evolution of Organic Chemistry.” Angewandte Chemie International Edition 44, no. 44: 7263–7269.
Fogel, D. B. 2018. “Factors Associated With Clinical Trials That Fail and Opportunities for Improving the Likelihood of Success: A Review.” Contemporary Clinical Trials Communications 11: 156–164.
Frey, B. J., and D. Dueck. 2007. “Clustering by Passing Messages Between Data Points.” Science 315, no. 5814: 972–976.
Fu, J., and H. Yan. 2012. “Controlled Drug Release by a Nanorobot.” Nature Biotechnology 30, no. 5: 407–408.
Gallant, S. I. 1990. “Perceptron‐Based Learning Algorithms.” IEEE Transactions on Neural Networks 1, no. 2: 179–191.
Gams, M., M. Horvat, M. Ožek, M. Luštrek, and A. Gradišek. 2014. “Integrating Artificial and Human Intelligence Into Tablet Production Process.” AAPS PharmSciTech 15, no. 6: 1447–1453.
Gayvert, K. M., N. S. Madhukar, and O. Elemento. 2016. “A Data‐Driven Approach to Predicting Successes and Failures of Clinical Trials.” Cell Chemical Biology 23, no. 10: 1294–1301.
Gentleman, R., and V. J. Carey. 2008. “Unsupervised Machine Learning.” In Bioconductor Case Studies, 137–157. New York, NY: Springer.
Gnanasankaran, N., G. Rakesh, and T. Manikumar. 2022. “Multidisciplinary Applications of Machine Learning.” In Machine Learning, Blockchain, and Cyber Security in Smart Environments, 41–57. Florida: Chapman and Hall/CRC.
GNS Healthcare Announces Collaboration to Power Cancer Drug Development With REFS™ Causal Machine Learning and Simulation AI Platform. 2023. https://www.gnshealthcare.com/gns‐healthcare‐announces‐collaboration‐to‐power‐cancer‐drug‐development/.
Goh, W. Y., C. P. Lim, K. K. Peh, and K. Subari. 2002. “Application of a Recurrent Neural Network to Prediction of Drug Dissolution Profiles.” Neural Computing & Applications 10, no. 4: 311–317.
Gottlieb, A., G. Y. Stein, E. Ruppin, and R. Sharan. 2011. “PREDICT: A Method for Inferring Novel Drug Indications With Application to Personalized Medicine.” Molecular Systems Biology 7, no. 1: 496.
Guo, M., G. Kalra, W. Wilson, Y. Peng, and L. L. Augsburger. 2002. “A Prototype Intelligent Hybrid System for Hard Gelatin Capsule Formulation Development.” Pharmaceutical Technology 6: 44–52.
Hammerstrom, D. 1993. “Working With Neural Networks.” IEEE Spectrum 30, no. 7: 46–53.
Hammett, L. P. 1937. “The Effect of Structure Upon the Reactions of Organic Compounds. Benzene Derivatives.” Journal of the American Chemical Society 59, no. 1: 96–103.
Handelman, G. S., H. K. Kok, R. V. Chandra, et al. 2019. “Peering Into the Black Box of Artificial Intelligence: Evaluation Metrics of Machine Learning Methods.” American Journal of Roentgenology 212, no. 1: 38–43.
Hansch, C., and T. Fujita. 1964. “P‐σ‐π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure.” Journal of the American Chemical Society 86, no. 8: 1616–1626.
Harrer, S., P. Shah, B. Antony, and J. Hu. 2019. “Artificial Intelligence for Clinical Trial Design.” Trends in Pharmacological Sciences 40, no. 8: 577–591.
Hassanzadeh, P., F. Atyabi, and R. Dinarvand. 2019. “The Significance of Artificial Intelligence in Drug Delivery System Design.” Advanced Drug Delivery Reviews 151: 169–190.
Hearst, M. A., S. T. Dumais, E. Osuna, J. Platt, and B. Scholkopf. 1998. “Support Vector Machines.” IEEE Intelligent Systems and Their Applications 13, no. 4: 18–28.
Hegelich, S. 2023. “Defining Machine Learning.” In Digital Phenotyping and Mobile Sensing, 455–460. GmbH, Germany: Springer.
Hekkelman, M. L., I. de Vries, R. P. Joosten, and A. Perrakis. 2023. “AlphaFill: Enriching AlphaFold Models With Ligands and Cofactors.” Nature Methods 20, no. 2: 205–213. https://doi.org/10.1038/s41592‐022‐01685‐y.
Ho, T. K. 1995. “Random Decision Forests.” Paper Presented at the Proceedings of 3rd International Conference on Document Analysis and Recognition.
Hou, T., W. Zhang, D. A. Case, and W. Wang. 2008. “Characterization of Domain–Peptide Interaction Interface: A Case Study on the Amphiphysin‐1 SH3 Domain.” Journal of Molecular Biology 376, no. 4: 1201–1214.
Howard, J. 2019. “Artificial Intelligence: Implications for the Future of Work.” American Journal of Industrial Medicine 62, no. 11: 917–926.
Huang, Q., L.‐L. Li, and S.‐Y. Yang. 2011. “RASA: A Rapid Retrosynthesis‐Based Scoring Method for the Assessment of Synthetic Accessibility of Drug‐Like Molecules.” Journal of Chemical Information and Modeling 51: 2768–2777.
Hurle, M. R., L. Yang, Q. Xie, D. K. Rajpal, P. Sanseau, and P. Agarwal. 2013. “Computational Drug Repositioning: From Data to Therapeutics.” Clinical Pharmacology & Therapeutics 93, no. 4: 335–341.
Iorio, F., R. Bosotti, E. Scacheri, et al. 2010. “Discovery of Drug Mode of Action and Drug Repositioning From Transcriptional Responses.” Proceedings of the National Academy of Sciences of the United States of America 107, no. 33: 14621–14626.
Iorio, F., R. L. Shrestha, N. Levin, et al. 2015. “A Semi‐Supervised Approach for Refining Transcriptional Signatures of Drug Response and Repositioning Predictions.” PLoS One 10, no. 10: e0139446.
Jafarzadeh, A., M. Nemati, and S. Jafarzadeh. 2021. “Contribution of STAT3 to the Pathogenesis of COVID‐19.” Microbial Pathogenesis 154: 104836.
Jalkala, A. M., and J. Keränen. 2014. “Brand Positioning Strategies for Industrial Firms Providing Customer Solutions.” Journal of Business & Industrial Marketing 29: 253–264.
Janiesch, C., P. Zschech, and K. Heinrich. 2021. “Machine Learning and Deep Learning.” Electronic Markets 31, no. 3: 685–695.
Jimenez‐Carretero, D., V. Abrishami, L. Fernandez‐de‐Manuel, et al. 2018. “Tox_ (R) CNN: Deep Learning‐Based Nuclei Profiling Tool for Drug Toxicity Screening.” PLoS Computational Biology 14, no. 11: e1006238.
Johnson, K. B., W. Q. Wei, D. Weeraratne, et al. 2021. “Precision Medicine, AI, and the Future of Personalized Health Care.” Clinical and Translational Science 14, no. 1: 86–93.
Jordan, M. I., and T. M. Mitchell. 2015. “Machine Learning: Trends, Perspectives, and Prospects.” Science 349, no. 6245: 255–260.
Jumper, J., R. Evans, A. Pritzel, et al. 2021. “Highly Accurate Protein Structure Prediction With AlphaFold.” Nature 596, no. 7873: 583–589. https://doi.org/10.1038/s41586‐021‐03819‐2.
Kalafatis, S. P., M. H. Tsogas, and C. Blankson. 2000. “Positioning Strategies in Business Markets.” Journal of Business & Industrial Marketing 15: 416–437.
Kalra, G., Y. Peng, M. Guo, and L. L. Augsburger. 2002. “A Hybrid Intelligent System for Formulation of BCS Class II Drugs in Hard Gelatin Capsules.” Paper Presented at the Proceedings of the 9th International Conference on Neural Information Processing, 2002. ICONIP'02.
Kerru, N., S. V. Bhaskaruni, L. Gummidi, S. N. Maddila, S. Maddila, and S. B. Jonnalagadda. 2019. “Recent Advances in Heterogeneous Catalysts for the Synthesis of Imidazole Derivatives.” Synthetic Communications 49, no. 19: 2437–2459.
Ketterhagen, W. R., M. T. Am Ende, and B. C. Hancock. 2009. “Process Modeling in the Pharmaceutical Industry Using the Discrete Element Method.” Journal of Pharmaceutical Sciences 98, no. 2: 442–470.
Khurana, D., A. Koli, K. Khatter, and S. Singh. 2023. “Natural Language Processing: State of the Art, Current Trends and Challenges.” Multimedia Tools and Applications 82, no. 3: 3713–3744.
King, R. D., J. D. Hirst, and M. J. Sternberg. 1995. “Comparison of Artificial Intelligence Methods for Modeling Pharmaceutical QSARS.” Applied Artificial Intelligence an International Journal 9, no. 2: 213–233.
Krogh, A. 2008. “What Are Artificial Neural Networks?” Nature Biotechnology 26, no. 2: 195–197.
Kumar, A., S. Vembu, A. K. Menon, and C. Elkan. 2013. “Beam Search Algorithms for Multilabel Learning.” Machine Learning 92: 65–89.
Kumar, B., A. Thakur, A. R. Dwivedi, R. Kumar, and V. Kumar. 2022. “Multi‐Target‐Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease.” Current Medicinal Chemistry 29, no. 10: 1757–1803.
Lai, S. 1996. “An Expert System to Aid the Development of Capsule Formulations.” Pharmaceutical Technology Europe 8: 60–68.
Law, J., Z. Zsoldos, A. Simon, et al. 2009. “Route Designer: A Retrosynthetic Analysis Tool Utilizing Automated Retrosynthetic Rule Generation.” Journal of Chemical Information and Modeling 49, no. 3: 593–602.
LeCun, Y., Y. Bengio, and G. Hinton. 2015. “Deep Learning.” Nature 521, no. 7553: 436–444.
Liu, G., D. B. Catacutan, K. Rathod, et al. 2023. “Deep Learning‐Guided Discovery of an Antibiotic Targeting Acinetobacter baumannii.” Nature Chemical Biology 19: 1–9.
Liu, T., M. Naderi, C. Alvin, S. Mukhopadhyay, and M. Brylinski. 2017. “Break Down in Order to Build Up: Decomposing Small Molecules for Fragment‐Based Drug Design With eMolFrag.” Journal of Chemical Information and Modeling 57, no. 4: 627–631.
Liu, X., S. C. Rivera, D. Moher, M. J. Calvert, and A. K. Denniston. 2020. “Reporting Guidelines for Clinical Trial Reports for Interventions Involving Artificial Intelligence: The CONSORT‐AI Extension.” BMJ 2, no. 10: e537–e548.
Liu, X., C. Shi, U. Deore, et al. 2021. “A Scalable AI Approach for Clinical Trial Cohort Optimization.” Paper Presented at the Joint European Conference on Machine Learning and Knowledge Discovery in Databases.
Lounkine, E., M. J. Keiser, S. Whitebread, et al. 2012. “Large‐Scale Prediction and Testing of Drug Activity on Side‐Effect Targets.” Nature 486, no. 7403: 361–367.
Luo, M., Y. Feng, T. Wang, and J. Guan. 2018. “Micro‐/Nanorobots at Work in Active Drug Delivery.” Advanced Functional Materials 28, no. 25: 1706100.
Luo, Y., X. Zhao, J. Zhou, et al. 2017. “A Network Integration Approach for Drug–Target Interaction Prediction and Computational Drug Repositioning From Heterogeneous Information.” Nature Communications 8, no. 1: 1–13.
Lusci, A., G. Pollastri, and P. Baldi. 2013. “Deep Architectures and Deep Learning in Chemoinformatics: The Prediction of Aqueous Solubility for Drug‐Like Molecules.” Journal of Chemical Information and Modeling 53, no. 7: 1563–1575.
Mak, K.‐K., and M. R. Pichika. 2019. “Artificial Intelligence in Drug Development: Present Status and Future Prospects.” Drug Discovery Today 24, no. 3: 773–780.
Mamoshina, P., A. Vieira, E. Putin, and A. Zhavoronkov. 2016. “Applications of Deep Learning in Biomedicine.” Molecular Pharmaceutics 13, no. 5: 1445–1454.
Mao, J., J. Wang, A. Zeb, et al. 2023. “Transformer‐Based Molecular Generative Model for Antiviral Drug Design.” Journal of Chemical Information and Modeling 64, no. 7: 2733–2745.
Marr, B. 2018. “How Is AI Used in Education—Real World Examples of Today and a Peek Into the Future.” Forbes Magazine 25.
Martin, E. J., V. R. Polyakov, L. Tian, and R. C. Perez. 2017. “Profile‐QSAR 2.0: Kinase Virtual Screening Accuracy Comparable to Four‐Concentration IC50s for Realistically Novel Compounds.” Journal of Chemical Information and Modeling 57, no. 8: 2077–2088.
Martinelli, D. D. 2022. “Generative Machine Learning for De Novo Drug Discovery: A Systematic Review.” Computers in Biology and Medicine 145: 105403.
Marvin, M., and A. P. Seymour. 1969. Perceptrons. Vol. 6, 318–362. Cambridge, MA: MIT Press.
Mayr, A., G. Klambauer, T. Unterthiner, and S. Hochreiter. 2016. “DeepTox: Toxicity Prediction Using Deep Learning.” Frontiers in Environmental Science 3: 80.
McCulloch, W. S., and W. Pitts. 1943. “A Logical Calculus of the Ideas Immanent in Nervous Activity.” Bulletin of Mathematical Biophysics 5, no. 4: 115–133.
McInerney, C. E., J. A. Lynn, A. R. Gilmore, T. Flannery, and K. M. Prise. 2022. “Using AI‐Based Evolutionary Algorithms to Elucidate Adult Brain Tumor (Glioma) Etiology Associated With IDH1 for Therapeutic Target Identification.” Current Issues in Molecular Biology 44, no. 7: 2982–3000.
Mehta, C. H., R. Narayan, and U. Y. Nayak. 2019. “Computational Modeling for Formulation Design.” Drug Discovery Today 24, no. 3: 781–788.
Mei, J.‐P., C.‐K. Kwoh, P. Yang, X.‐L. Li, and J. Zheng. 2013. “Drug–Target Interaction Prediction by Learning From Local Information and Neighbors.” Bioinformatics 29, no. 2: 238–245.
Mintz, Y., and R. Brodie. 2019. “Introduction to Artificial Intelligence in Medicine.” Minimally Invasive Therapy & Allied Technologies 28, no. 2: 73–81.
Mitchell, T. M., and T. M. Mitchell. 1997. Machine Learning. Vol. 1. New York: McGraw‐Hill.
Mohapatra, B. N., and P. P. Panda. 2019. “Machine Learning Applications to Smart City.” ACCENTS Transactions on Image Processing and Computer Vision 5, no. 14: 1–6.
Naderi, M., C. Alvin, Y. Ding, S. Mukhopadhyay, and M. Brylinski. 2016. “A Graph‐Based Approach to Construct Target‐Focused Libraries for Virtual Screening.” Journal of Cheminformatics 8: 1–16.
Nadkarni, P. M., L. Ohno‐Machado, and W. W. Chapman. 2011. “Natural Language Processing: An Introduction.” Journal of the American Medical Informatics Association 18, no. 5: 544–551.
Nussinov, R., M. Zhang, Y. Liu, and H. Jang. 2023. “AlphaFold, Allosteric, and Orthosteric Drug Discovery: Ways Forward.” Drug Discovery Today 28, no. 6: 103551. https://doi.org/10.1016/j.drudis.2023.103551.
Ourmazd, A., K. Moffat, and E. E. Lattman. 2022. “Structural Biology Is Solved—Now What?” Nature Methods 19, no. 1: 24–26. https://doi.org/10.1038/s41592‐021‐01357‐3.
Padlipsky, M. A. 1982. “Perspective on the ARPANET Reference Model (2070‐1721).” rfc871.
Paloque‐Bergès, C., and V. Schafer. 2019. “Arpanet (1969–2019).” Internet Histories 3, no. 1: 1–14.
Patil, V. M., N. Masand, S. Verma, and V. Masand. 2021. “Chromones: Privileged Scaffold in Anticancer Drug Discovery.” Chemical Biology & Drug Design 98, no. 5: 943–953.
Patlewicz, G., N. Jeliazkova, R. Safford, A. Worth, and B. Aleksiev. 2008. “An Evaluation of the Implementation of the Cramer Classification Scheme in the Toxtree Software.” SAR and QSAR in Environmental Research 19, no. 5–6: 495–524.
Paul, D., G. Sanap, S. Shenoy, D. Kalyane, K. Kalia, and R. K. Tekade. 2021. “Artificial Intelligence in Drug Discovery and Development.” Drug Discovery Today 26, no. 1: 80–93.
Pedretti, A., A. Mazzolari, S. Gervasoni, and G. Vistoli. 2020. “Tree2C: A Flexible Tool for Enabling Model Deployment With Special Focus on Cheminformatics Applications.” Applied Sciences 10, no. 21: 7704.
Pereira, J. C., E. R. Caffarena, and C. N. Dos Santos. 2016. “Boosting Docking‐Based Virtual Screening With Deep Learning.” Journal of Chemical Information and Modeling 56, no. 12: 2495–2506.
Perrakis, A., and T. K. Sixma. 2021. “AI Revolutions in Biology.” EMBO Reports 22, no. 11: e54046. https://doi.org/10.15252/embr.202154046.
Pfeifer, R., and F. Iida. 2004. “Embodied Artificial Intelligence: Trends and Challenges.” Embodied Artificial Intelligence, 1–26. International Seminar, Dagstuhl Castle, Germany, July 7‐11, 2003.
Popova, M., O. Isayev, and A. Tropsha. 2018. “Deep Reinforcement Learning for De Novo Drug Design.” Science Advances 4, no. 7: eaap7885.
Prakash, C., R. Kumar, and N. Mittal. 2018. “Recent Developments in Human Gait Research: Parameters, Approaches, Applications, Machine Learning Techniques, Datasets and Challenges.” Artificial Intelligence Review 49, no. 1: 1–40.
Pu, L., M. Naderi, T. Liu, H.‐C. Wu, S. Mukhopadhyay, and M. Brylinski. 2019. “eToxPred: A Machine Learning‐Based Approach to Estimate the Toxicity of Drug Candidates.” BMC Pharmacology and Toxicology 20: 1–15.
Putin, E., A. Asadulaev, Y. Ivanenkov, et al. 2018. “Reinforced Adversarial Neural Computer for De Novo Molecular Design.” Journal of Chemical Information and Modeling 58, no. 6: 1194–1204.
Rantanen, J., and J. Khinast. 2015. “The Future of Pharmaceutical Manufacturing Sciences.” Journal of Pharmaceutical Sciences 104, no. 11: 3612–3638.
Reddy, A. S., and S. Zhang. 2013. “Polypharmacology: Drug Discovery for the Future.” Expert Review of Clinical Pharmacology 6, no. 1: 41–47.
Reiter, E., and R. Dale. 1997. “Building Applied Natural Language Generation Systems.” Natural Language Engineering 3, no. 1: 57–87.
Reymond, J.‐L., R. Van Deursen, L. C. Blum, and L. Ruddigkeit. 2010. “Chemical Space as a Source for New Drugs.” MedChemComm 1, no. 1: 30–38.
Richardson, P., I. Griffin, C. Tucker, et al. 2020. “Baricitinib as Potential Treatment for 2019‐nCoV Acute Respiratory Disease.” Lancet 395, no. 10223: e30–e31.
Riesterer, N., D. Brand, and M. Ragni. 2020. “Predictive Modeling of Individual Human Cognition: Upper Bounds and a New Perspective on Performance.” Topics in Cognitive Science 12, no. 3: 960–974.
Rivera, S. C., X. Liu, A.‐W. Chan, et al. 2020. “Guidelines for Clinical Trial Protocols for Interventions Involving Artificial Intelligence: The SPIRIT‐AI Extension.” Lancet Digital Health 2, no. 10: e549–e560.
Rodgers, W., J. M. Murray, A. Stefanidis, W. Y. Degbey, and S. Y. Tarba. 2023. “An Artificial Intelligence Algorithmic Approach to Ethical Decision‐Making in Human Resource Management Processes.” Human Resource Management Review 33, no. 1: 100925.
Roy, R., and H. M. Al‐Hashimi. 2024. “AlphaFold3 Takes a Step Toward Decoding Molecular Behavior and Biological Computation.” Nature Structural & Molecular Biology 31, no. 7: 997–1000. https://doi.org/10.1038/s41594‐024‐01350‐2.
Rupp, M., and G. Schneider. 2010. “Graph Kernels for Molecular Similarity.” Molecular Informatics 29, no. 4: 266–273.
Ryu, J. Y., H. U. Kim, and S. Y. Lee. 2018. “Deep Learning Improves Prediction of Drug–Drug and Drug–Food Interactions.” Proceedings of the National Academy of Sciences of the United States of America 115, no. 18: E4304–E4311.
Schank, R. C. 1972. “Conceptual Dependency: A Theory of Natural Language Understanding.” Cognitive Psychology 3, no. 4: 552–631.
Schmidt, J., M. R. G. Marques, S. Botti, and M. A. L. Marques. 2019. “Recent Advances and Applications of Machine Learning in Solid‐State Materials Science.” Npj Computational Materials 5, no. 1: 83. https://doi.org/10.1038/s41524‐019‐0221‐0.
Schneider, G. 2018. “Automating Drug Discovery.” Nature Reviews Drug Discovery 17, no. 2: 97–113.
Schneider, P., W. P. Walters, A. T. Plowright, et al. 2020. “Rethinking Drug Design in the Artificial Intelligence Era.” Nature Reviews Drug Discovery 19, no. 5: 353–364.
Seddon, G., V. Lounnas, R. McGuire, et al. 2012. “Drug Design for Ever, From Hype to Hope.” Journal of Computer‐Aided Molecular Design 26, no. 1: 137–150.
Segler, M. H., T. Kogej, C. Tyrchan, and M. P. Waller. 2018. “Generating Focused Molecule Libraries for Drug Discovery With Recurrent Neural Networks.” ACS Central Science 4, no. 1: 120–131.
Segler, M. H., M. Preuss, and M. P. Waller. 2018. “Planning Chemical Syntheses With Deep Neural Networks and Symbolic AI.” Nature 555, no. 7698: 604–610.
Sharma, V., S. Rai, and A. Dev. 2012. “A Comprehensive Study of Artificial Neural Networks.” International Journal of Advanced Research in Computer Science and Software Engineering 2, no. 10: 278–284.
Shaw, G. L. 1986. “Donald Hebb: The Organization of Behavior.” In Brain Theory, 231–233. New York, NY: Springer.
Signorelli, C. M. 2018. “Can Computers Become Conscious and Overcome Humans?” Frontiers in Robotics and AI 5: 121. https://doi.org/10.3389/frobt.2018.00121.
Singh, A., G. Madaan, H. Swapna, and A. Kumar. 2023. “Impact of Artificial Intelligence on Human Capital in Healthcare Sector Post‐COVID‐19.” In The Adoption and Effect of Artificial Intelligence on Human Resources Management, Part A, 47–69. Leeds, England: Emerald Publishing Limited.
Singh, Y., P. K. Bhatia, and O. Sangwan. 2007. “A Review of Studies on Machine Learning Techniques.” International Journal of Computer Science and Security 1, no. 1: 70–84.
Skayneh, H., B. Jishi, R. Hleihel, et al. 2022. “EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML.” International Journal of Molecular Sciences 23, no. 7: 3421.
Sollini, M., F. Bartoli, A. Marciano, R. Zanca, R. H. Slart, and P. A. Erba. 2020. “Artificial Intelligence and Hybrid Imaging: The Best Match for Personalized Medicine in Oncology.” European Journal of Hybrid Imaging 4, no. 1: 1–22.
Struble, T. J., J. C. Alvarez, S. P. Brown, et al. 2020. “Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis.” Journal of Medicinal Chemistry 63, no. 16: 8667–8682.
Sun, H., P. Pan, S. Tian, et al. 2016. “Constructing and Validating High‐Performance MIEC‐SVM Models in Virtual Screening for Kinases: A Better Way for Actives Discovery.” Scientific Reports 6, no. 1: 1–12.
Sutton, R. S. 1992. “Introduction: The Challenge of Reinforcement Learning.” In Reinforcement Learning, 1–3. Boston, MA: Springer.
Szklarczyk, D., A. L. Gable, D. Lyon, et al. 2019. “STRING v11: Protein–Protein Association Networks With Increased Coverage, Supporting Functional Discovery in Genome‐Wide Experimental Datasets.” Nucleic Acids Research 47, no. D1: D607–D613.
Szymkuć, S., E. P. Gajewska, T. Klucznik, et al. 2016. “Computer‐Assisted Synthetic Planning: The End of the Beginning.” Angewandte Chemie International Edition 55, no. 20: 5904–5937.
Takigawa, I., and H. Mamitsuka. 2013. “Graph Mining: Procedure, Application to Drug Discovery and Recent Advances.” Drug Discovery Today 18, no. 1–2: 50–57.
Tan, B. K. J., C. B. Teo, X. Tadeo, et al. 2021. “Personalised, Rational, Efficacy‐Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE. AI Pilot Clinical Trial.” Frontiers in Digital Health 3: 635524.
Tetko, I. V. 2002. “Associative Neural Network.” Neural Processing Letters 16, no. 2: 187–199.
Thompson, W. R., A. J. Reinisch, M. J. Unterberger, and A. J. Schriefl. 2019. “Artificial Intelligence‐Assisted Auscultation of Heart Murmurs: Validation by Virtual Clinical Trial.” Pediatric Cardiology 40, no. 3: 623–629.
Tiwari, P. C., R. Pal, M. J. Chaudhary, and R. Nath. 2023. “Artificial Intelligence Revolutionizing Drug Development: Exploring Opportunities and Challenges.” Drug Development Research 84: 1652–1663.
Tucker, A. B. 2004. Computer Science Handbook. Florida: Chapman and Hall/CRC.
Villaverde, J. E., D. Godoy, and A. Amandi. 2006. “Learning Styles' Recognition in e‐Learning Environments With Feed‐Forward Neural Networks.” Journal of Computer Assisted Learning 22, no. 3: 197–206.
Voulodimos, A., N. Doulamis, A. Doulamis, and E. Protopapadakis. 2018. “Deep Learning for Computer Vision: A Brief Review.” Computational Intelligence and Neuroscience 2018: 7068349. https://doi.org/10.1155/2018/7068349.
Wachsmuth, I. 2000. “The Concept of Intelligence in AI.” In Prerational Intelligence: Adaptive Behavior and Intelligent Systems Without Symbols and Logic, Volume 1, Volume 2 Prerational Intelligence: Interdisciplinary Perspectives on the Behavior of Natural and Artificial Systems, Volume 3, 43–55. Dordrecht: Springer.
Wang, F., D. Liu, H. Wang, et al. 2011. “Computational Screening for Active Compounds Targeting Protein Sequences: Methodology and Experimental Validation.” Journal of Chemical Information and Modeling 51, no. 11: 2821–2828.
Wang, M., Y. Cui, X. Wang, S. Xiao, and J. Jiang. 2017. “Machine Learning for Networking: Workflow, Advances and Opportunities.” IEEE Network 32, no. 2: 92–99.
Wang, Q., Y. Feng, J. Huang, T. Wang, and G. Cheng. 2017. “A Novel Framework for the Identification of Drug Target Proteins: Combining Stacked Auto‐Encoders With a Biased Support Vector Machine.” PLoS One 12, no. 4: e0176486.
Wang, X., S. Allen, J. F. Blake, et al. 2022. “Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor.” Journal of Medicinal Chemistry 65, no. 4: 3123–3133. https://doi.org/10.1021/acs.jmedchem.1c01688.
Waqas, A., A. R. Gilal, Z. Bhatti, and A. W. Mahessar. 2013. “Investigating ANNs and Applications.” Indian Journal of Automation and Artificial Intelligence 1, no. 2: 65–69.
Wei, J. N., D. Duvenaud, and A. Aspuru‐Guzik. 2016. “Neural Networks for the Prediction of Organic Chemistry Reactions.” ACS Central Science 2, no. 10: 725–732.
Weinstein, J. N., K. W. Kohn, M. R. Grever, et al. 1992. “Neural Computing in Cancer Drug Development: Predicting Mechanism of Action.” Science 258, no. 5081: 447–451.
Weissler, E. H., T. Naumann, T. Andersson, et al. 2021. “The Role of Machine Learning in Clinical Research: Transforming the Future of Evidence Generation.” Trials 22, no. 1: 1–15.
Wessel, M. D., P. C. Jurs, J. W. Tolan, and S. M. Muskal. 1998. “Prediction of Human Intestinal Absorption of Drug Compounds From Molecular Structure.” Journal of Chemical Information and Computer Sciences 38, no. 4: 726–735.
Wilkinson, J., K. F. Arnold, E. J. Murray, et al. 2020. “Time to Reality Check the Promises of Machine Learning‐Powered Precision Medicine.” Lancet Digital Health 2, no. 12: e677–e680.
World Health Organization. 2021. Ethics and Governance of Artificial Intelligence for Health: WHO Guidance. Geneva, Switzerland: World Health Organization.
Xia, Z., L.‐Y. Wu, X. Zhou, and S. T. Wong. 2010. “Semi‐Supervised Drug–Protein Interaction Prediction From Heterogeneous Biological Spaces.” Paper Presented at the BMC Systems Biology.
Xiao, X., J.‐L. Min, W.‐Z. Lin, Z. Liu, X. Cheng, and K.‐C. Chou. 2015. “iDrug‐Target: Predicting the Interactions Between Drug Compounds and Target Proteins in Cellular Networking via Benchmark Dataset Optimization Approach.” Journal of Biomolecular Structure and Dynamics 33, no. 10: 2221–2233.
Xiong, Y., Y. Wang, Y. Wang, et al. 2023. “Improving Drug Discovery With a Hybrid Deep Generative Model Using Reinforcement Learning Trained on a Bayesian Docking Approximation.” Journal of Computer‐Aided Molecular Design 37: 1–11.
Xu, Y., J. Pei, and L. Lai. 2017. “Deep Learning Based Regression and Multiclass Models for Acute Oral Toxicity Prediction With Automatic Chemical Feature Extraction.” Journal of Chemical Information and Modeling 57, no. 11: 2672–2685.
Yampolskiy, R. V. 2019. “Predicting Future AI Failures From Historic Examples.” Foresight 21, no. 1: 138–152.
Yan, X.‐Y., S.‐W. Zhang, and S.‐Y. Zhang. 2016. “Prediction of Drug–Target Interaction by Label Propagation With Mutual Interaction Information Derived From Heterogeneous Network.” Molecular BioSystems 12, no. 2: 520–531.
Yan, Y., W. Wang, Z. Sun, J. Z. Zhang, and C. Ji. 2017. “Protein–Ligand Empirical Interaction Components for Virtual Screening.” Journal of Chemical Information and Modeling 57, no. 8: 1793–1806.
Yang, X., Y. Wang, R. Byrne, G. Schneider, and S. Yang. 2019. “Concepts of Artificial Intelligence for Computer‐Assisted Drug Discovery.” Chemical Reviews 119, no. 18: 10520–10594.
Yu, H., J. Chen, X. Xu, et al. 2012. “A Systematic Prediction of Multiple Drug–Target Interactions From Chemical, Genomic, and Pharmacological Data.” PLoS One 7, no. 5: e37608.
Zang, Q., K. Mansouri, A. J. Williams, et al. 2017. “In Silico Prediction of Physicochemical Properties of Environmental Chemicals Using Molecular Fingerprints and Machine Learning.” Journal of Chemical Information and Modeling 57, no. 1: 36–49.
Zarrinpar, A., D.‐K. Lee, A. Silva, et al. 2016. “Individualizing Liver Transplant Immunosuppression Using a Phenotypic Personalized Medicine Platform.” Science Translational Medicine 8, no. 333: 333ra349.
Zeng, X., S. Zhu, W. Lu, et al. 2020. “Target Identification Among Known Drugs by Deep Learning From Heterogeneous Networks.” Chemical Science 11, no. 7: 1775–1797.
Zhang, C., and Y. Lu. 2021. “Study on Artificial Intelligence: The State of the Art and Future Prospects.” Journal of Industrial Information Integration 23: 100224.
Zhang, L., J. Tan, D. Han, and H. Zhu. 2017. “From Machine Learning to Deep Learning: Progress in Machine Intelligence for Rational Drug Discovery.” Drug Discovery Today 22, no. 11: 1680–1685.
Zhang, P., P. Agarwal, and Z. Obradovic. 2013. “Computational Drug Repositioning by Ranking and Integrating Multiple Data Sources.” Paper Presented at the Joint European Conference on Machine Learning and Knowledge Discovery in Databases.
Zhao, C., A. Jain, L. Hailemariam, et al. 2006. “Toward Intelligent Decision Support for Pharmaceutical Product Development.” Journal of Pharmaceutical Innovation 1, no. 1: 23–35.
Zhou, T., S. Jhamb, X. Liang, K. Sundmacher, and R. Gani. 2018. “Prediction of Acid Dissociation Constants of Organic Compounds Using Group Contribution Methods.” Chemical Engineering Science 183: 95–105.
Zhuang, D., and A. K. Ibrahim. 2021. “Deep Learning for Drug Discovery: A Study of Identifying High Efficacy Drug Compounds Using a Cascade Transfer Learning Approach.” Applied Sciences 11, no. 17: 7772.
Contributed Indexing:
Keywords: artificial intelligence; deep learning; drug discovery; machine learning; neural networks; pharmaceuticals
Entry Date(s):
Date Created: 20241013 Date Completed: 20241013 Latest Revision: 20241013
Update Code:
20250114
DOI:
10.1111/cbdd.14639
PMID:
39396920
Database:
MEDLINE
Weitere Informationen
The technological revolutions in computers and the advancement of high-throughput screening technologies have driven the application of artificial intelligence (AI) for faster discovery of drug molecules with more efficiency, and cost-friendly finding of hit or lead molecules. The ability of software and network frameworks to interpret molecular structures' representations and establish relationships/correlations has enabled various research teams to develop numerous AI platforms for identifying new lead molecules or discovering new targets for already established drug molecules. The prediction of biological activity, ADME properties, and toxicity parameters in early stages have reduced the chances of failure and associated costs in later clinical stages, which was observed at a high rate in the tedious, expensive, and laborious drug discovery process. This review focuses on the different AI and machine learning (ML) techniques with their applications mainly focused on the pharmaceutical industry. The applications of AI frameworks in the identification of molecular target, hit identification/hit-to-lead optimization, analyzing drug-receptor interactions, drug repurposing, polypharmacology, synthetic accessibility, clinical trial design, and pharmaceutical developments are discussed in detail. We have also compiled the details of various startups in AI in this field. This review will provide a comprehensive analysis and outline various state-of-the-art AI/ML techniques to the readers with their framework applications. This review also highlights the challenges in this field, which need to be addressed for further success in pharmaceutical applications.
(© 2024 The Author(s). Chemical Biology & Drug Design published by John Wiley & Sons Ltd.)